Top compounds associated with response to PSMD7


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC -0.077 0.02
mRNA EX-527 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.071 0.02
mRNA XMD11-85h GDSC1000 pan-cancer AAC -0.11 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV